Skip to main content
OpenTrials
Completed

NCT Number: NCT05637489

Patient Initiated Note About Goals

This is a randomized controlled trial of the Patient-Initiated Note about Goals (PING).

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Duke Health

Durham, North Carolina, 27710, United States

About this study

The PING is a brief survey designed to elicit patients' goals, preferences, and preferred surrogate decision-maker. In the PING study, patients will be assigned to receive either a nurse-administered PING or usual care. Outcomes include PING completion, subsequent goals of care conversations with providers, and healthcare utilization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient referred for Annual Wellness Visit at participating clinic

Exclusion criteria

  • Non-English speaking

Treatment and study plan

PING

Behavioral

Brief survey of goals and preferences

Primary outcomes

  1. Number of participants with subsequent goals of care conversation

    Time frame: 2 months

    Conversation documented in EHR (electronic health record)

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Acronym: PING

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2022
Registry last updated
Oct 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.